The most outstanding
Grupo SURA ended the year 2025 with a recurring net income of COP 2.3 trillion
Publicado el 27 February 2026
Grupo SURA marks 15 years in the S&P Global Sustainability Yearbook
Publicado el 19 February 2026
Notice of the Upcoming Ordinary Annual Shareholders' Meeting - 2026
Publicado el 18 February 2026
News Center
VaxThera, a SURA company, inaugurated its vaccine packaging and finishing plant in Colombia
Publicado el 15 May 2024
Grupo SURA has appointed a new Chief Executive Officer
Publicado el 25 April 2024
Year-end report
Publicado el 10 April 2024
Board of Directors Appointments for the Period 2024 - 2026
Publicado el 02 April 2024
Signing of a material financing agreement on the part of the subsidiary SURA Asset Management
Publicado el 26 March 2024